PMC:7275137 / 12495-12802 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T53","span":{"begin":37,"end":46},"obj":"Body_part"},{"id":"T54","span":{"begin":47,"end":58},"obj":"Body_part"}],"attributes":[{"id":"A53","pred":"fma_id","subj":"T53","obj":"http://purl.org/sig/ont/fma/fma67180"},{"id":"A54","pred":"fma_id","subj":"T54","obj":"http://purl.org/sig/ont/fma/fma76577"}],"text":"e endolysosomal pathway by targeting endosomal compartment pH through different mechanisms such as inhibition of vacuolar-type H+-ATPase (V-ATPase). In the following text, these compounds are considered as potential candidate drugs with antiviral effects (Fig. 2 ). As many pharmacological agents have shown"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T81","span":{"begin":226,"end":231},"obj":"Chemical"},{"id":"T82","span":{"begin":237,"end":246},"obj":"Chemical"}],"attributes":[{"id":"A81","pred":"chebi_id","subj":"T81","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"id":"A82","pred":"chebi_id","subj":"T82","obj":"http://purl.obolibrary.org/obo/CHEBI_22587"}],"text":"e endolysosomal pathway by targeting endosomal compartment pH through different mechanisms such as inhibition of vacuolar-type H+-ATPase (V-ATPase). In the following text, these compounds are considered as potential candidate drugs with antiviral effects (Fig. 2 ). As many pharmacological agents have shown"}

{"project":"LitCovid-sentences","denotations":[{"id":"T65","span":{"begin":149,"end":265},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"e endolysosomal pathway by targeting endosomal compartment pH through different mechanisms such as inhibition of vacuolar-type H+-ATPase (V-ATPase). In the following text, these compounds are considered as potential candidate drugs with antiviral effects (Fig. 2 ). As many pharmacological agents have shown"}

{"project":"LitCovid-PubTator","denotations":[{"id":"216","span":{"begin":59,"end":61},"obj":"Gene"}],"attributes":[{"id":"A216","pred":"tao:has_database_id","subj":"216","obj":"Gene:5053"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"e endolysosomal pathway by targeting endosomal compartment pH through different mechanisms such as inhibition of vacuolar-type H+-ATPase (V-ATPase). In the following text, these compounds are considered as potential candidate drugs with antiviral effects (Fig. 2 ). As many pharmacological agents have shown"}